Survival in HFpEF vs HFrEF patients after beta-blocker titration: new insights from the CIBIS-ELD trial
30 August 2016 (14:00 - 18:00)
Organised by:
About the speaker

Scirent - Clinical Research and Science, Berlin (Germany)
49 More presentations in this session
Access the full session
The Event
ESC Congress 2016
30 August 2016
14:00 CET
